Colorectal cancer screening rates could increase if the Shield test appeals to people who have avoided colonoscopies or stool-based tests, the company said.
Guardant wins FDA approval for colon cancer blood test Read More »
MedTech Dive caught up with Chief Medical Officer Jordan Pinsker to talk about early feedback on Tandem’s smallest insulin pump and what’s next for the device.
Tandem CMO shares Mobi feedback, expansion plans Read More »
Hospitals in China increased internal approval cycles to comply with anti-corruption measures.
Philips’ orders and sales held back by China’s anti-corruption push Read More »
En el dinámico mundo de la tecnología, las herramientas de análisis de datos y visualización se han convertido en componentes esenciales para las empresas que buscan tomar decisiones informadas y estratégicas. Entre estas herramientas, Power BI de Microso …
Power BI, la tecnología que gana adeptos sin parar Read More »
The health system posted a $13 million net loss, even as surgical and outpatient volumes climbed.
Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.
Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline Read More »
With the BIOSECURE Act likely to be voted on in Congress this year, WuXi AppTec’s U.S. revenue dropped 1.2% in the first half of 2024 while the Chinese company increased its lobbying efforts.
WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms Read More »
En la interminable carrera por captar el mayor número posible de clientes potenciales, las empresas de juegos de azar tratan de ofrecer una experiencia completa en la que cada detalle se personaliza para adaptarse a las necesidades de cada cliente en particular. En consecuencia, el …
The cuts will affect urgent care locations, primary and specialty care clinics, and infusion centers, as well as office and remote workers.
Optum to lay off more than 500 workers in California Read More »
The combination therapy is one step closer to becoming a potential new first-line standard of care for patients with unresectable or metastatic urothelial carcinoma in Europe.
